Results 311 to 320 of about 422,827 (356)
Some of the next articles are maybe not open access.

Head and neck cancer

Cancer and Metastasis Reviews, 2003
In this review, the authors outline the epidemiology, genetic factors, treatment and outcomes of head and neck cancer.
Steve, McMahon, Amy Y, Chen
openaire   +2 more sources

Head and neck cancer

Emergency Nurse, 2016
A diagnosis of head and neck cancer can be physically and emotionally debilitating. The condition and its treatment can affect breathing, eating and communicating, and change physical appearance. Head and neck cancer can have profound effects on psychological and psychosocial well-being and subsequent quality of life.
openaire   +2 more sources

Taxanes In Head and Neck Cancer

Future Oncology, 2005
Paclitaxel and docetaxel are cytotoxic agents that act on the microtubule system and cause cell death. They are active in patients with squamous cell carcinoma of the head and neck region. They can be combined with other cytotoxic agents and radiotherapy with acceptable toxicity.
Schrijvers, Dirk, Vermorken, Jan B.
openaire   +3 more sources

Head and Neck Cancers

Primary Care: Clinics in Office Practice
Head and neck cancers are heterogenous cancers with rising incidence of treatable/curative cancers. They are treated comprehensively by multidisciplinary teams. Survivors of head and neck cancers often deal with the sequalae of therapy and with increasing survival rates, it is anticipated that the primary care physicians are going to encounter more ...
Archana, Kudrimoti, Mahesh R, Kudrimoti
openaire   +2 more sources

Head and neck cancer

Ugeskrift for Læger
Head and neck cancer includes tumours of the oral cavity, pharynx, larynx, sinonasal region, salivary glands, and thyroid. The majority are squamous cell carcinomas. The incidence is rising, primarily due to an increase in HPV-related cancers. HPV-positive tumours have a better prognosis than those caused by smoking and alcohol.
Kathrine Kronberg, Jakobsen   +1 more
openaire   +4 more sources

Prevalence of trismus in patients with head and neck cancer: A systematic review with meta‐analysis

Head and Neck, 2019
The purpose of this systematic review and meta‐analysis was to determine the prevalence of trismus in patients with head and neck cancer.
Amber L Watters   +4 more
semanticscholar   +1 more source

The chemotherapy of head and neck cancer

Anti-Cancer Drugs, 1999
Studies of combination therapy [with agents such as cisplatin, 5-fluorouracil (5-FU) and methotrexate] have shown some improvements in response rate; however, no obvious survival advantage over monotherapy in the treatment of patients with metastatic or advanced locoregional cancer of the head and neck have been observed.
openaire   +5 more sources

Chemotherapy in head and neck cancer

Plastic and Reconstructive Surgery, 1966
CHEMOTHERAPY in head and neck cancer had its clinical beginning in December 1942. Gilman and Philips, 1 Hunt and Philips, 2 and Goodman et al 3 while studying top secret nitrogen mustard and its biological behavior at Yale University discovered its cytotoxic role when absorbed. Following extensive studies on animal tumors it was first used in man under
openaire   +2 more sources

Cancer of the Head and Neck

JAMA, 1972
ABSTRACT The nasopharynx is a small boxlike structure at the top of the pharyngeal cylinder. Neoplasms spread in two directions, each leading to distinct neurological signs. Direct extension through the foramen lacerum into the cavernous sinus and middle fossa of the skull leads to the involvement of cranial nerves III, IV, V, VI, and more rarely ...
openaire   +2 more sources

Head and neck cancer

Critical Reviews in Oncology/Hematology, 1998
L, Barzan, U, Tirelli, J L, Lefebvre
openaire   +2 more sources

Home - About - Disclaimer - Privacy